English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/177463
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Soluble epoxide hydrolase inhibition as a new therapeutic strategy for the treatment of alzheimer's disease.

AuthorsGaldeano, Carles; Griñán-Ferré, Christian; Codony, Sandra; Pujol, Eugènia; Yang, Jun; Leiva, Rosana; Escolano, Carmen; Puigoriol-Illamola, Dolors; Companys-Alemany, Júlia; Corpas, Rubén ; Sanfeliu, Coral ; Morissea, Christophe; Hammock, Bruce D.; Vázque, Santiago; Pallàs, Mercè
Issue Date3-Sep-2018
CitationXXV EFMC International Symposium on Medicinal Chemistry (2018)
DescriptionTrabajo presentado en la XXV EFMC International Symposium on Medicinal Chemistry (European Federation for Medicinal Chemistry), celebrada en Ljubljana, Slovenia, del 2 al 6 de septiembre de 2018
Appears in Collections:(IIBB) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.